Tirdzniecība LifeStance Health Group - LFST CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Tirdzniecības Nosacījumi
| Starpība | 0.08 | ||||||||
|
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.030779% | ||||||||
|
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | -0.013666% | ||||||||
| Nakts laika nodeva | 22:00 (UTC) | ||||||||
| Min. tirgotais daudzums | 1 | ||||||||
| Valūta | USD | ||||||||
| Drošības rezerve | 20% | ||||||||
| Fondu birža | United States of America | ||||||||
| Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Galvenie Statistikas Dati
| Iepriekš. aizvērt* | 5.21 |
| Atvērt* | 5.09 |
| Izmaiņas par 1 gadu* | -28.91% |
| Dienas Diapazons* | 5.09 - 5.32 |
| 52 ned Diapazons | 4.22-11.25 |
| Vidējais apjoms (10 dienas) | 391.95K |
| Vidējais apjoms (3 mēneši) | 10.45M |
| Tirgus Kapitalizācija | 1.97B |
| Cenas/Peļņas Attiecība | -100.00K |
| Izvietotās Akcijas | 375.99M |
| Ieņēmumi | 820.18M |
| EPS | -0.79 |
| Dividende (Ienesīgums %) | N/A |
| Beta | -100.00K |
| Nākamās Peļņas Datums | N/A |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
|---|---|---|---|---|---|---|
| Feb 6, 2023 | 5.21 | -0.10 | -1.88% | 5.31 | 5.50 | 5.03 |
| Feb 3, 2023 | 5.51 | 0.33 | 6.37% | 5.18 | 5.65 | 5.16 |
| Feb 2, 2023 | 5.39 | 0.02 | 0.37% | 5.37 | 5.53 | 5.22 |
| Feb 1, 2023 | 5.34 | 0.16 | 3.09% | 5.18 | 5.41 | 5.14 |
| Jan 31, 2023 | 5.25 | 0.08 | 1.55% | 5.17 | 5.34 | 5.10 |
| Jan 30, 2023 | 5.24 | -0.03 | -0.57% | 5.27 | 5.52 | 5.18 |
| Jan 27, 2023 | 5.49 | 0.41 | 8.07% | 5.08 | 5.62 | 5.08 |
| Jan 26, 2023 | 5.21 | -0.10 | -1.88% | 5.31 | 5.31 | 5.05 |
| Jan 25, 2023 | 5.22 | 0.18 | 3.57% | 5.04 | 5.26 | 4.96 |
| Jan 24, 2023 | 5.17 | 0.19 | 3.82% | 4.98 | 5.40 | 4.98 |
| Jan 23, 2023 | 5.14 | -0.01 | -0.19% | 5.15 | 5.31 | 4.98 |
| Jan 20, 2023 | 5.18 | 0.19 | 3.81% | 4.99 | 5.33 | 4.86 |
| Jan 19, 2023 | 5.02 | -0.11 | -2.14% | 5.13 | 5.21 | 4.92 |
| Jan 18, 2023 | 5.29 | -0.02 | -0.38% | 5.31 | 5.49 | 5.11 |
| Jan 17, 2023 | 5.39 | 0.26 | 5.07% | 5.13 | 5.50 | 5.02 |
| Jan 13, 2023 | 5.29 | 0.23 | 4.55% | 5.06 | 5.40 | 5.02 |
| Jan 12, 2023 | 5.17 | 0.09 | 1.77% | 5.08 | 5.19 | 4.86 |
| Jan 11, 2023 | 5.06 | 0.13 | 2.64% | 4.93 | 5.16 | 4.76 |
| Jan 10, 2023 | 4.94 | 0.17 | 3.56% | 4.77 | 5.05 | 4.56 |
| Jan 9, 2023 | 4.93 | 0.30 | 6.48% | 4.63 | 5.01 | 4.59 |
LifeStance Health Group Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Ikgadējs
- Ceturkšņa
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Kopējie ienākumi | 212.518 | 377.217 | 667.511 |
| Ienākumi | 212.518 | 377.217 | 667.511 |
| Kopējie Darbības Izdevumi | 199.463 | 398.965 | 972.026 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 179.633 | 311.303 | 430.54 |
| Depreciation / Amortization | 6.095 | 31.045 | 54.136 |
| Neparedzēti Izdevumi (Ienākumi) | 2.186 | 37.184 | 21.347 |
| Other Operating Expenses, Total | 11.549 | 19.433 | 466.003 |
| Darbības Izdevumi | 13.055 | -21.748 | -304.515 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -5.409 | -22.132 | -24.511 |
| Citi, Neto | 0.229 | -0.531 | -4.079 |
| Neto Ienākumi Pirms Nodokļu Nomaksas | 7.875 | -44.411 | -333.105 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | 5.669 | -38.07 | -307.197 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | 5.669 | -38.07 | -307.197 |
| Neto Ienākumi | 5.669 | -38.07 | -307.197 |
| Total Adjustments to Net Income | -64.573 | -273.244 | -36.75 |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -58.904 | -311.314 | -343.947 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -58.904 | -311.314 | -343.947 |
| Atšķaidītie Neto Ienākumi | -58.904 | -311.314 | -343.947 |
| Atšķaidītie Ienākumi par Akcijām | 373.649 | 373.649 | 327.523 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -0.15765 | -0.83317 | -1.05015 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | |
| Atšķaidītā Normalizētā Peļņa par Akciju | -0.15343 | -0.7687 | -0.97291 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Kopējie ienākumi | 143.132 | 160.549 | 173.835 | 189.995 | 203.095 |
| Ienākumi | 143.132 | 160.549 | 173.835 | 189.995 | 203.095 |
| Kopējie Darbības Izdevumi | 145.547 | 223.99 | 298.629 | 303.86 | 268.224 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 32.019 | 84.935 | 162.047 | 151.539 | 101.575 |
| Depreciation / Amortization | 12.228 | 12.774 | 13.777 | 15.357 | 15.684 |
| Neparedzēti Izdevumi (Ienākumi) | 2.166 | 16.94 | 1.022 | 1.219 | 2.072 |
| Other Operating Expenses, Total | 99.134 | 109.341 | 121.783 | 135.745 | 148.893 |
| Darbības Izdevumi | -2.415 | -63.441 | -124.794 | -113.865 | -65.129 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -8.632 | -8.774 | -3.503 | -3.602 | -3.441 |
| Citi, Neto | -0.396 | -1.606 | -0.906 | -1.171 | -0.434 |
| Neto Ienākumi Pirms Nodokļu Nomaksas | -11.443 | -73.821 | -129.203 | -118.638 | -69.004 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | -8.682 | -70.033 | -120.452 | -108.03 | -62.328 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | -8.682 | -70.033 | -120.452 | -108.03 | -62.328 |
| Neto Ienākumi | -8.682 | -70.033 | -120.452 | -108.03 | -62.328 |
| Total Adjustments to Net Income | -36.75 | 0 | 0 | 0 | 0 |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -45.432 | -70.033 | -120.452 | -108.03 | -62.328 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -45.432 | -70.033 | -120.452 | -108.03 | -62.328 |
| Atšķaidītie Neto Ienākumi | -45.432 | -70.033 | -120.452 | -108.03 | -62.328 |
| Atšķaidītie Ienākumi par Akcijām | 373.649 | 313.536 | 343.394 | 346.243 | 350.849 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -0.12159 | -0.22337 | -0.35077 | -0.31201 | -0.17765 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Atšķaidītā Normalizētā Peļņa par Akciju | -0.11782 | -0.14689 | -0.34883 | -0.31418 | -0.17381 |
- Ikgadējs
- Ceturkšņa
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 27.425 | 76.28 | 266.52 |
| Nauda un Īstermiņa Ieguldījumi | 3.481 | 18.829 | 148.029 |
| Nauda un Ekvivalenti | 3.481 | 18.829 | 148.029 |
| Debitoru Parādu Kopsumma, Neto | 19.13 | 46.934 | 94.695 |
| Accounts Receivable - Trade, Net | 18.633 | 43.706 | 76.078 |
| Prepaid Expenses | 4.814 | 10.517 | 19.454 |
| Total Assets | 280.779 | 1569.73 | 1927.11 |
| Property/Plant/Equipment, Total - Net | 22.426 | 59.349 | 152.242 |
| Property/Plant/Equipment, Total - Gross | 26.717 | 63.781 | 171.768 |
| Accumulated Depreciation, Total | -4.291 | -4.432 | -19.526 |
| Goodwill, Net | 214.614 | 1098.66 | 1204.54 |
| Intangibles, Net | 14.951 | 332.796 | 300.355 |
| Other Long Term Assets, Total | 1.363 | 2.647 | 3.448 |
| Total Current Liabilities | 55.007 | 75.921 | 116.752 |
| Accounts Payable | 3.642 | 7.688 | 14.152 |
| Accrued Expenses | 23.545 | 46.98 | 76.055 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Other Current Liabilities, Total | 27.82 | 17.515 | 25.222 |
| Total Liabilities | 144.221 | 536.895 | 382.081 |
| Total Long Term Debt | 79.314 | 362.534 | 157.416 |
| Long Term Debt | 79.314 | 362.534 | 157.416 |
| Deferred Income Tax | 0.863 | 81.226 | 54.281 |
| Other Liabilities, Total | 9.037 | 17.214 | 53.632 |
| Total Equity | 136.558 | 1032.84 | 1545.03 |
| Preferred Stock - Non Redeemable, Net | 302.913 | 0 | 0 |
| Common Stock | 0.003 | 1044.51 | 3.743 |
| Additional Paid-In Capital | 0 | 1.452 | 1898.36 |
| Retained Earnings (Accumulated Deficit) | -166.358 | -13.125 | -357.072 |
| Total Liabilities & Shareholders’ Equity | 280.779 | 1569.73 | 1927.11 |
| Total Common Shares Outstanding | 373.649 | 373.649 | 374.255 |
| Current Port. of LT Debt/Capital Leases | 3.738 | 1.323 | |
| Other Current Assets, Total | 4.342 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 109.578 | 364.06 | 328.326 | 266.52 | 263.297 |
| Nauda un Īstermiņa Ieguldījumi | 39.494 | 276.187 | 212.123 | 148.029 | 113.99 |
| Nauda un Ekvivalenti | 39.494 | 276.187 | 212.123 | 148.029 | 113.99 |
| Debitoru Parādu Kopsumma, Neto | 47.768 | 60.069 | 70.059 | 76.078 | 94.991 |
| Accounts Receivable - Trade, Net | 47.768 | 60.069 | 70.059 | 76.078 | 94.991 |
| Prepaid Expenses | 22.316 | 27.804 | 46.144 | 42.413 | 54.316 |
| Total Assets | 1606.28 | 1914.43 | 1914.76 | 1927.11 | 1958.39 |
| Property/Plant/Equipment, Total - Net | 70.802 | 91.799 | 115.049 | 152.242 | 170.927 |
| Property/Plant/Equipment, Total - Gross | 77.843 | 101.91 | 129.125 | 171.768 | 196.18 |
| Accumulated Depreciation, Total | -7.041 | -10.111 | -14.076 | -19.526 | -25.253 |
| Goodwill, Net | 1099.68 | 1138.73 | 1160.01 | 1204.54 | 1229.3 |
| Intangibles, Net | 323.302 | 316.534 | 307.982 | 300.355 | 291.18 |
| Other Long Term Assets, Total | 2.926 | 3.3 | 3.388 | 3.448 | 3.679 |
| Total Current Liabilities | 96.757 | 112.558 | 105.205 | 116.752 | 125.597 |
| Accounts Payable | 5.913 | 9.958 | 3.074 | 14.152 | 15.136 |
| Accrued Expenses | 71.024 | 89.163 | 85.934 | 86.512 | 95.014 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 19.82 | 11.818 | 14.874 | 14.765 | 14.124 |
| Total Liabilities | 580.524 | 369.795 | 369.887 | 382.081 | 415.868 |
| Total Long Term Debt | 387.298 | 157.067 | 157.447 | 157.416 | 177.38 |
| Long Term Debt | 387.298 | 157.067 | 157.447 | 157.416 | 177.38 |
| Deferred Income Tax | 81.226 | 81.219 | 81.226 | 54.281 | 54.281 |
| Other Liabilities, Total | 15.243 | 18.951 | 26.009 | 53.632 | 58.61 |
| Total Equity | 1025.76 | 1544.63 | 1544.87 | 1545.03 | 1542.52 |
| Common Stock | 1082.26 | 3.742 | 3.742 | 3.743 | 3.744 |
| Additional Paid-In Capital | 2.057 | 1669.48 | 1790.17 | 1898.36 | 1958.17 |
| Retained Earnings (Accumulated Deficit) | -58.557 | -128.59 | -249.042 | -357.072 | -419.4 |
| Total Liabilities & Shareholders’ Equity | 1606.28 | 1914.43 | 1914.76 | 1927.11 | 1958.39 |
| Total Common Shares Outstanding | 373.649 | 373.649 | 374.149 | 374.255 | 374.323 |
| Current Port. of LT Debt/Capital Leases | 1.619 | 1.323 | 1.323 | 1.323 | |
| Preferred Stock - Non Redeemable, Net | 0 | 0 |
- Ikgadējs
- Ceturkšņa
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Neto ienākumi/Sākuma Līnija | 5.669 | -38.07 | -307.197 |
| Nauda no Darbības | 17.048 | -8.533 | 9.42 |
| Nauda no Darbības | 6.095 | 31.045 | 54.136 |
| Deferred Taxes | 1.76 | -6.501 | -26.945 |
| Bezskaidras Naudas Preces | 0.532 | 5.746 | 287.286 |
| Cash Taxes Paid | 0.254 | 0.246 | 1.093 |
| Samaksātie Procenti Naudā | 4.582 | 17.149 | 22.415 |
| Izmaiņas Apgrozāmajā Kapitālā | 2.992 | -0.753 | 2.14 |
| Nauda no Ieguldījumu Darbībām | -73.375 | -861.169 | -194.076 |
| Kapitālie Izdevumi | -14.314 | -38.066 | -94.492 |
| Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -59.061 | -823.103 | -99.584 |
| Nauda no Darbībām ar Finansēšanu | 48.463 | 912.274 | 313.856 |
| Naudas Plūsma Finansēšanas Posteņos | -6.987 | 600.867 | -11.18 |
| Akciju Izsniegšana (Atkāpšanās), Neto | 0 | 20 | 549.905 |
| Parādu Izsniegšana (Atkāpšanās), Neto | 55.45 | 291.407 | -224.869 |
| Neto Izmaiņas Naudā | -7.864 | 42.572 | 129.2 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -8.682 | -78.715 | -199.167 | -307.197 | -62.328 |
| Cash From Operating Activities | 9.909 | -7.006 | -21.215 | 9.42 | 3.308 |
| Cash From Operating Activities | 12.228 | 25.002 | 38.779 | 54.136 | 15.684 |
| Deferred Taxes | 0 | 0 | 0 | -26.945 | |
| Non-Cash Items | 1.315 | 46.378 | 168.39 | 287.286 | 60.584 |
| Cash Interest Paid | 6.806 | 24.889 | 28.217 | 22.415 | 3.091 |
| Changes in Working Capital | 5.048 | 0.329 | -29.217 | 2.14 | -10.632 |
| Cash From Investing Activities | -11.835 | -70.929 | -114.514 | -194.076 | -50.855 |
| Capital Expenditures | -11.081 | -31.803 | -55.815 | -94.492 | -27.91 |
| Other Investing Cash Flow Items, Total | -0.754 | -39.126 | -58.699 | -99.584 | -22.945 |
| Cash From Financing Activities | 22.591 | 335.293 | 329.023 | 313.856 | 13.508 |
| Financing Cash Flow Items | -2.824 | -7.947 | -8.622 | -11.18 | -6.161 |
| Issuance (Retirement) of Stock, Net | 0 | 555.169 | 549.905 | 549.905 | |
| Issuance (Retirement) of Debt, Net | 25.415 | -211.929 | -212.26 | -224.869 | 19.669 |
| Net Change in Cash | 20.665 | 257.358 | 193.294 | 129.2 | -34.039 |
| Cash Taxes Paid | 0.9 | 0.908 | 1.093 | -0.06 |
| Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
|---|---|---|---|---|---|---|
| TPG Capital, L.P. | Private Equity | 46.6199 | 175284635 | 0 | 2022-09-30 | LOW |
| Summit Partners, L.P. | Private Equity | 12.1639 | 45734703 | 0 | 2022-09-30 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 7.5946 | 28554650 | -2973463 | 2022-09-30 | LOW |
| Lester (Michael K.) | Individual Investor | 5.7172 | 21495968 | -328615 | 2022-06-13 | LOW |
| Silversmith Capital Partners | Private Equity | 5.1973 | 19541192 | 0 | 2021-12-31 | |
| Qureshi (Danish J.) | Individual Investor | 2.5754 | 9683096 | -85879 | 2022-06-13 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.8602 | 6994133 | 832246 | 2022-09-30 | LOW |
| Stockbridge Partners LLC | Investment Advisor/Hedge Fund | 1.8169 | 6831137 | 15000 | 2022-09-30 | LOW |
| Booth (Gwendolyn H.) | Individual Investor | 1.7375 | 6532649 | -88798 | 2022-06-13 | LOW |
| Gouk (Warren) | Individual Investor | 1.586 | 5962991 | -15106 | 2022-11-07 | LOW |
| Mullins (Kevin Michael) | Individual Investor | 1.4853 | 5584540 | -82520 | 2022-09-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.2332 | 4636558 | 937454 | 2022-09-30 | LOW |
| Principal Global Investors (Equity) | Investment Advisor | 1.0256 | 3856290 | 488665 | 2022-09-30 | LOW |
| Bessler (Robert) | Individual Investor | 0.8087 | 3040694 | 0 | 2022-04-06 | LOW |
| Fidelity Institutional Asset Management | Investment Advisor | 0.6928 | 2604875 | 1070087 | 2022-09-30 | LOW |
| Rock Springs Capital Management LP | Hedge Fund | 0.5319 | 2000000 | 0 | 2022-09-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.4645 | 1746348 | 502175 | 2022-09-30 | LOW |
| Bruff (Jesse Michael) | Individual Investor | 0.4239 | 1586606 | -230098 | 2022-04-25 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.3729 | 1402221 | 256009 | 2022-09-30 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.3515 | 1321716 | -149365 | 2021-12-31 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group +500000+
Tirgotāji
93000+
Ikmēneša aktīvie klienti
$57000000+
Ikmēneša ieguldījumu apjoms
$31000000+
Izmēģināt tagad Izņemts katru mēnesi
Treidinga kalkulators
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Tirdzniecības komisija
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Finanšu svira
20:1
- 20
- 100
- 500
- 1000
- 10000
Investīcija
Darījuma apjoms (Kredītplecs x Investīcija):
Atvēršana
Aizvēršana
Īss Garšs
LifeStance Health Company profile
Par LifeStance Health Group
LifeStance Health Group, Inc. ir garīgās veselības aprūpes uzņēmums. Uzņēmums koncentrējas uz uz pierādījumiem balstītu, medicīniski pamatotu ārstēšanas pakalpojumu sniegšanu bērniem, pusaudžiem un pieaugušajiem, kas cieš no dažādām garīgās veselības problēmām, ambulatorās aprūpes apstākļos gan klātienē, gan izmantojot digitālās veselības telemedicīnas piedāvājumu. Uzņēmuma ārsti piedāvā pacientiem dažādus garīgās veselības pakalpojumus, tostarp psihiatrisko izvērtēšanu un ārstēšanu, psiholoģisko un neiropsiholoģisko testēšanu, kā arī individuālo, ģimenes un grupu terapiju. Tās uz pacientiem orientētā platforma apvieno diferencētas klīniskās iespējas ar personalizētu, digitāli darbināmu pacientu pieredzi, kas paredzēta, lai uzlabotu pacientu piekļuvi un ārstēšanu. Tā ārstē dažādus garīgās veselības stāvokļus, tostarp trauksmi, depresiju, bipolārus traucējumus, ēšanas traucējumus, psihotiskus traucējumus un posttraumatiskus stresa traucējumus. Uzņēmumā darbojas aptuveni 534 centri un strādā vairāk nekā 4800 klīnicistu visā ASV.
| Industry: | Healthcare Facilities & Services (NEC) |
4800 N. Scottsdale Road
Suite 6000
SCOTTSDALE
ARIZONA 85251
US
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 500 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com